FIELD: biomedical technologies.
SUBSTANCE: invention relates to biomedical technologies, and specifically to a group of methods aimed at changing the conductivity of cell membranes to control cell activity. A nucleic acid encoding a thermosensitive human TRPV1 channel with altered ion selectivity (TRPV1ΔCa2+), which provides depolarization of the cell membrane and lacks the conductivity of divalent calcium cations, has been proposed, having the sequence SEQ ID NO: 01.
EFFECT: exclusion of damage and death of excitable cells due to their overload with calcium ions during thermogenetic control of transmembrane transport of cations using the human TRPV1 channel.
1 cl, 5 dwg, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF CONTROL OF HEART RHYTHM AND REDUCTION OF INDIVIDUAL CARDIOMYOCYTES USING THERMOGENETICS | 2022 |
|
RU2802995C1 |
| ANTIGEN-BINDING MOLECULE INDUCING AN IMMUNE RESPONSE TO A TARGET ANTIGEN | 2012 |
|
RU2722829C2 |
| POLYPEPTIDES RECRUITING T-CELLS, CAPABLE OF BINDING CD123 AND ALPHA/BETA TCR | 2017 |
|
RU2775063C2 |
| LIBRARY OF CONCENTRATION-DEPENDENT BINDING MOLECULES | 2012 |
|
RU2732151C2 |
| ANTIGEN-BINDING MOLECULE CAPABLE OF MULTIPLE BINDING TO A VARIETY OF ANTIGEN MOLECULES | 2018 |
|
RU2757786C2 |
| MODIFIED NON-NATURAL NKG2D LIGANDS WHICH SELECTIVELY DELIVER ATTACHED HETEROLOGOUS MOLECULES TO NON-NATURAL NKG2D RECEPTORS ON CAR CELLS | 2020 |
|
RU2823728C2 |
| BINDING MOLECULES, BINDING PD-L1 AND LAG-3 | 2017 |
|
RU2784388C2 |
| CELL | 2014 |
|
RU2717984C2 |
| CELL | 2014 |
|
RU2732236C2 |
| Therapeutic antibodies to CD47 | 2016 |
|
RU2748401C2 |
